BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Endometrial Cancer|Head and Neck Cancer|Melanoma (Skin)|Ovarian Cancer|Sarcoma
Interventions: DRUG: BI 2536|OTHER: high performance liquid chromatography|OTHER: mass spectrometry|OTHER: pharmacological study
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC